Cardio Diagnostics Holdings, Inc. (CDIO)
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
$6.58M
Dr. Meeshanthini Dogan Ph.D.
3.00
Chicago, IL
Jan 14, 2022
-0.69
$-0.40
3.48
5.69
-22,415.27%
-0.72
-0.02
2.06
171.35
5.69
-219.50%
-308.99%
Similar stocks (9)
Pyxis Oncology, Inc.
PYXS
Immix Biopharma, Inc.
IMMX
Elevation Oncology, Inc.
ELEV
Sonnet BioTherapeutics Holdings, Inc.
SONN
CNS Pharmaceuticals, Inc.
CNSP
Phio Pharmaceuticals Corp.
PHIO
180 Life Sciences Corp.
ATNF
eFFECTOR Therapeutics, Inc.
EFTR
Navidea Biopharmaceuticals, Inc.
NAVB
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (9)
Pyxis Oncology, Inc.
PYXS
Immix Biopharma, Inc.
IMMX
Elevation Oncology, Inc.
ELEV
Sonnet BioTherapeutics Holdings, Inc.
SONN
CNS Pharmaceuticals, Inc.
CNSP
Phio Pharmaceuticals Corp.
PHIO
180 Life Sciences Corp.
ATNF
eFFECTOR Therapeutics, Inc.
EFTR
Navidea Biopharmaceuticals, Inc.
NAVB
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%